The new COVID-19 variant, Omicron, has been designated as a variant of concern by the World Health Organization, with widespread speculation the existing COVID-19 vaccines may not be as resistant to it.
New formulations to vaccines may be needed, with Pfizer saying it could tweak its existing vaccine within 100 days and Moderna announcing it could achieve the same result by early 2022.
To read the article click here